**7.1 Introduction**

This approach is used rarely and required in only for the patients who have contraindications to all other accesses. Modine reported a successful series of 12 patients who underwent CoreValve TAVI with no access site complications, no stroke, and only 1 TIA contralateral to the accessed side [16].

Mylotte et al. [17] reported the feasibility and the safety of this transcarotid approach in 96 patients enrolled in 3 different French sites. In their series, no major bleedings nor vascular complications related to the access site occurred, while only three transient ischemic attacks and no strokes were reported.
